To investigate the effect of GR deletion in podocytes on the initiation and progression of diabetic nephropathy, we induced diabetes mellitus in control and GRPKO mice with streptozotocin and monitored mice for 16 weeks (Figure 1A). The gene discussed is NR3C1; the disease is diabetic kidney disease.